ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Distribution Deals in Medical Devices 2016-2025 | Market Value, Financial Terms Exhibited - ResearchAndMarkets.com

The "Distribution Deals in Medical Devices 2016 to 2025" has been added to ResearchAndMarkets.com's offering.

This report contains a comprehensive listing of distribution deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual distribution contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Distribution Deals in Medical Devices provides a detailed understanding and analysis of how and why companies enter distribution deals. Fully revised and updated, the report provides details of distribution deals from 2016 to 2025. The report provides access to distribution deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not. The initial chapters of this report provide an essential orientation on distribution dealmaking and related business activities.

Chapter 1 serves as an introduction, while Chapter 2 delves into trends and offers an analysis of distribution, alongside a discussion on the benefits of different types of deals. Chapter 3 outlines the structure typical of distribution deals. Chapter 4 reviews the top distribution deals since 2016, organized by headline value and includes links to agreement contracts, if available. Chapter 5 lists the top 25 most active distribution dealmakers, with hyperlinks to detailed records and contracts where available. This comprehensive review gives potential dealmakers the insights they need for successful distribution alliances.

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

2.1. Introduction

2.2. Definition of distribution deal

2.3. Trends in distribution deals since 2016

2.3.1. Distribution dealmaking by year, 2016-2025

2.3.2. Distribution dealmaking by phase of development, 2016-2025

2.3.3. Distribution dealmaking by therapy area, 2016-2025

2.3.4. Distribution dealmaking by technology type, 2016-2025

2.3.5. Distribution dealmaking by most active company, 2016-2025

2.4. Reasons for entering into distribution partnering deals

Chapter 3 - Overview of distribution deal structure

3.1. Introduction

3.2. Distribution agreement structure

Chapter 4 - Leading distribution deals

4.1. Introduction

4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

5.1. Introduction

5.2. Top 25 most active distribution dealmakers

Companies Featured

  • 3D Systems
  • AAP Implantate AG
  • Ab Medica
  • AccuTec Blades
  • Aesthetic Solutions
  • Agilent Technologies
  • AliMed
  • Altamira Therapeutics
  • American Aires
  • AMI
  • Andrec
  • Argon Medical Devices
  • Arjo
  • Arteriae
  • AstraZeneca
  • Aurolab
  • Bandgrip
  • Bayer AG
  • BD (Becton, Dickinson and Company)
  • B Braun
  • Bearpac Medical
  • BioIntelliSense
  • bioMerieux
  • Biotronik
  • Boston Scientific
  • CAIRE Inc.
  • CARDIONET
  • Celularity
  • Charles River Laboratories
  • Cook Medical
  • Cryolife
  • Daavlin
  • DePuy
  • DGSHAPE Corp
  • Direct Flow Medical
  • EDAP TMS
  • Elekta
  • EmboMedics
  • Fujifilm Holdings Corporation
  • Getinge AB
  • GlaxoSmithKline
  • Halyard Health
  • Helios Laboratories
  • Hologic
  • Integra LifeSciences
  • Intersurgical
  • Johnson & Johnson
  • Karl Storz
  • Leica Microsystems
  • Masimo Corporation

For more information about this report visit https://www.researchandmarkets.com/r/36p86g

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.